No results for ‘’
Entero Healthcare Solutions Ltd
₹1089.40
(1.46%)
Mon, 22 Jun 2026, 09:25 am
Distribution Services
Medical Distributors
24.5KEntero Healthcare Solutions EV/EBITDA Ratio
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 91.09 | 52.22 |
| Price to book ratio | 0 | 0 | 0 | 2.62 | 2.87 |
| Price to sales ratio | 0 | 0 | 0 | 0.91 | 0.97 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 | 3011Cr | 4921Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 26.92 | 28.59 |
| Debt to equity ratio | 0.42 | 0.63 | 0.74 | 0.21 | 0.22 |
| Return on equity % | 0 | -5.72 | -2 | 3.50 | 5.64 |
Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio
The Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Entero Healthcare Solutions Ltd's valuation, profitability, and overall financial performance. Tracking the Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Entero Healthcare Solutions Ltd (NSE: ENTERO, BSE: 544122) is currently trading at ₹1089.40, with a market capitalization of ₹4751.53Cr. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio Current Value
The current Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio stands at 28.59.
The latest Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 28.59
- 2023: 26.92
- 2022: 0
- 2021: 0
- 2020: 0
The recent rise in Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.
What Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Entero Healthcare Solutions Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.